RedChip Visibility Issues Research Update On MedaSorb Technologies, Inc.


ORLANDO, Fla., Jan. 10, 2007 (PRIME NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, announced today that they have issued a research update on MedaSorb Technologies (OTCBB:MSBT).

Lisa Springer, MBA/CFA, RedChip Senior Research Analyst, wrote in the report:

"MedaSorb Technologies, Inc. is developing new technologies for the purification of blood to treat both acute and chronic disease conditions. Its lead product, CytoSorb(tm), has applications in the treatment of sepsis, cardiopulmonary bypass surgery, organ donation transplantation and drug overdoses. MedaSorb filed an Investigational Device Exemption (IDE) supplement with the FDA for its CytoSorb(tm) product on January 4, 2007. The filing includes a proposed pilot study. If the pilot study is approved by the FDA, MedaSorb plans to commence clinical trials by third quarter 2007."

To receive a complimentary copy of the RedChip Research Report for MSBT, please visit: http://www.redchip.com/visibility/about.asp?page=requestMSBT_Q3_2006.

About RedChip Visibility(tm)

RedChip Visibility, a division of RedChip Companies Inc., writes fundamental research on small-cap companies. RedChip's success has been documented in Forbes, Barron's and the Wall Street Journal. RedChip Visibility(tm) provides small-cap companies access to both professional and individual small-cap investors by holding conferences throughout the United States, producing online corporate visibility programs, and writing company sponsored research.

The RedChip Companies Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2761

RedChip Visibility Research Disclosure

Any opinions expressed herein are subject to change. RedChip Companies Inc. is an affiliate of the Aurelius Consulting Group, Inc. MedaSorb Technologies, Inc. is a client of the Aurelius Consulting Group, Inc. and of RedChip Visibility, a division of RedChip Companies. MSBT paid RedChip Visibility $34,200 for the RedChip Visibility Research Program, which includes this report. RedChip Visibility, a division of RedChip Companies, Inc., and the Aurelius Consulting Group Inc., in a joint marketing agreement, have been contracted by MedaSorb Technologies, Inc. to increase investor awareness of MSBT to the small-cap equity community. These services may include investor conferences and digital and print distribution of MSBT investor related materials. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the Aurelius Consulting Group is an investor relations firm hired by the Company and receives a monthly fee of $9,500.



            

Mot-clé


Coordonnées